| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC3840 |
| Trial ID | NCT06353152 |
| Disease | Gastric Adenocarcinoma | Gastroesophageal-Junction Adenocarcinoma |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CLDN18.2 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | An Early Exploratory Clinical Trial of Claudin18.2-Targeted Chimeric Antigen Receptor T Cell Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma. |
| Year | 2023 |
| Country | China |
| Company sponsor | Peking University |
| Other ID(s) | GC506-507 |
| Cohort 1 | |||||||||
|
|||||||||